Image 1
Cyclobenzaprine Hydrochloride Capsule, Extended Release
Product Images NDC 24979-036
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 9 technical images submitted to the FDA as part of the official labeling for Cyclobenzaprine Hydrochloride (NDC 24979-036). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Upsher-smith Laboratories, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Image 2
Image 3
15 (Image 4)
Image 5
Image 6
Image 7
Image 8
Each extended-release capsule contains 15 g of Gyelobenzaprine hydrochloride USP (Cyclobenzaprine hydrochloride). These capsules should be stored at 20° to 25°C (68° to 77°F) in a tightly sealed container. The medication should be kept away from children. The manufacturer is Pramacesials and it is manufactured in Taiwan.*
Image 9
* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.
